AYTU CBO Jarrett Disbrow Receives 15,000-Share Award

What Happened Jarrett Disbrow, Chief Business Officer of AYTU Biopharma, was granted 15,000 restricted shares on July 28, 2026. The grant was recorded at $0.00 per share (no cash paid). This is an award/compensation grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-28; Form 4 filed 2026-07-30 (timely within the 2-business-day window).
• Amount: 15,000 restricted shares granted at $0.00 per share.
• Vesting (footnote): 1/3 (5,000 shares) vest on July 28, 2027; the remaining 10,000 shares vest in 8 equal quarterly installments of 1,250 shares starting October 28, 2027 (final installment 7/28/2029).
• Shares owned after transaction: not disclosed in this filing.
• No 10b5-1 plan, tax-withholding, or sale noted in the filing.

Context Restricted stock grants are typically compensation/retention awards that vest over time; they do not by themselves indicate a purchase-based bullish signal or an immediate sale. Monitor future Form 4s after vesting dates if Disbrow sells vested shares or otherwise changes holdings.